Tacrolimus: Difference between revisions
(special populations edits) |
(contraindications) |
||
| Line 37: | Line 37: | ||
==Contraindications== | ==Contraindications== | ||
*Allergy to class/drug | *Allergy to class/drug | ||
*hypersensitivity to castor oil derivatives (IV form) | |||
*liver transplant use (ER cap form) | |||
*electrolyte abnormalities, uncorrected | |||
*congenital long QT syndrome | |||
*caution if QT prolongation | |||
*caution if QT prolongation family hx | |||
*caution if torsades de pointes hx | |||
*caution if ventricular arrhythmias | |||
*caution if bradycardia | |||
*caution if recent MI | |||
*caution if CHF | |||
*caution in female pts | |||
*caution in black pts | |||
*caution in Hispanic pts | |||
*caution if renal impairment | |||
*caution if hepatic impairment | |||
==Adverse Reactions== | ==Adverse Reactions== | ||
Revision as of 03:26, 9 February 2016
Administration
- Type: immunosuppressant
- Dosage Forms: 0.5,1,5
- Routes of Administration: PO, topical, IV
- Common Trade Names:Prograf
Adult Dosing
Heart transplant rejection prophylaxis
- 0.075 mg/kg/day PO divided q12h
- Start: >6h post-transplant; Info: adjust dose based on serum levels
Liver transplant rejection prophylaxis
- 0.1-0.15 mg/kg/day PO divided q12h
- Start: >6h post-transplant; Info: adjust dose based on serum levels
Kidney transplant rejection prophylaxis
- 0.1-0.2 mg/kg/day PO divided q12h
- Start: w/in 24h post-transplant; delay if renal fxn not adequate; Info: adjust dose based on serum levels
Pediatric Dosing
Liver transplant rejection prophylaxis
- 0.15-0.2 mg/kg/day PO divided q12h
- Start: >6h post-transplant; Info: adjust dose based on serum levels
Special Populations
- Pregnancy Rating: Pregnancy Category C
- Lactation risk: possibly unsafe
Renal Dosing
- Adult:
- kidney transplant: give lowest recommended dose, may consider further dose decr.; postop oliguria: start 6-24h post-transplant; may delay until renal fxn adequate; HD: not defined
- all other transplants: give lowest recommended dose, may consider further dose decr.; HD: not defined
- Pediatric: give lowest recommended dose, may consider further dose decr.; HD: not defined
Hepatic Dosing
- Adult: give lowest recommended dose, may consider further dose decr.; Child-Pugh Score >10: decr. dose, amount not defined
- Pediatric: give lowest recommended dose, may consider further dose decr.; Child-Pugh Score >10: decr. dose, amount not defined
Contraindications
- Allergy to class/drug
- hypersensitivity to castor oil derivatives (IV form)
- liver transplant use (ER cap form)
- electrolyte abnormalities, uncorrected
- congenital long QT syndrome
- caution if QT prolongation
- caution if QT prolongation family hx
- caution if torsades de pointes hx
- caution if ventricular arrhythmias
- caution if bradycardia
- caution if recent MI
- caution if CHF
- caution in female pts
- caution in black pts
- caution in Hispanic pts
- caution if renal impairment
- caution if hepatic impairment
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
